Immunotherapy in Malignant Melanoma-Reference-Cited by-同舟云学术

Immunotherapy in Malignant Melanoma

Published:1999-06-01 Issue:6 Volume:17 Page:1963-1963
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Cassel William A.¹,Olkowski Z. L.¹,Murray Douglas R.¹

Affiliation:

1. Emory University School of Medicine, Atlanta, GA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.1999.17.6.1963

Reference2 articles.

1. Cassel WA, Murray DR: A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate. Med Oncol Tumor Pharmacother 9:169,1992-171

2. Savage HE, Rossen RD, Hersh EM, et al: Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells. Cancer Res 46:2127,1986-2133

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR4 Signaling Regulates Metastasis of Chemoresistant Melanoma Cells by a Lymphatic Metastatic Niche;Cancer Research;2010-11-05

2. Tumor Immunotherapy in Melanoma;American Journal of Clinical Dermatology;2008

3. Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus;Current Cancer Drug Targets;2007-03-01

4. Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo;Journal of Clinical Oncology;2004-06-01

5. Classical chemotherapy for metastatic melanoma;Clinical and Experimental Dermatology;2000-11